Brandywine Global Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-490,545
| Closed | -$461K | – | 585 |
|
|
2024
Q3 | $461K | Sell |
490,545
-209,100
| -30% | -$196K | ﹤0.01% | 633 |
|
|
2024
Q2 | $1.21M | Buy |
699,645
+143,700
| +26% | +$249K | 0.01% | 616 |
|
|
2024
Q1 | $1.33M | Hold |
555,945
| – | – | 0.01% | 607 |
|
|
2023
Q4 | $1.85M | Sell |
555,945
-110,300
| -17% | -$367K | 0.01% | 577 |
|
|
2023
Q3 | $2.49M | Buy |
666,245
+261,800
| +65% | +$979K | 0.02% | 514 |
|
|
2023
Q2 | $1.73M | Buy |
404,445
+354,100
| +703% | +$1.51M | 0.01% | 567 |
|
|
2023
Q1 | $344K | Hold |
50,345
| – | – | ﹤0.01% | 674 |
|
|
2022
Q4 | $399K | Hold |
50,345
| – | – | ﹤0.01% | 682 |
|
|
2022
Q3 | $484K | Sell |
50,345
-1,855
| -4% | -$17.8K | ﹤0.01% | 679 |
|
|
2022
Q2 | $378K | Sell |
52,200
-7,800
| -13% | -$56.5K | ﹤0.01% | 673 |
|
|
2022
Q1 | $775K | Hold |
60,000
| – | – | 0.01% | 637 |
|
|
2021
Q4 | $958K | Sell |
60,000
-15,106
| -20% | -$241K | 0.01% | 583 |
|
|
2021
Q3 | $1.21M | Sell |
75,106
-713
| -0.9% | -$11.5K | 0.01% | 566 |
|
|
2021
Q2 | $1.05M | Buy |
+75,819
| New | +$1.05M | 0.01% | 572 |
|
|
2021
Q1 | – | Sell |
-360,344
| Closed | -$6.26M | – | 677 |
|
|
2020
Q4 | $6.26M | Buy |
360,344
+51,120
| +17% | +$888K | 0.05% | 340 |
|
|
2020
Q3 | $5.67M | Buy |
309,224
+156,289
| +102% | +$2.87M | 0.06% | 300 |
|
|
2020
Q2 | $2.73M | Buy |
+152,935
| New | +$2.73M | 0.03% | 418 |
|